New lymphoma data support Antisoma's plans for AS1406 LONDON, Oct. 6, 2004 (PRIMEZONE) -- Cancer drug development company Antisoma plc (LSE:ASM) will today present further promising data for its targeted apoptosis drug AS1406. Speaking at the Human...

The Institute for International Research: Regulatory Intelligence Key to Decreasing FDA Approval Times -- Experts to Speak on Subject at IIR Conference NEW YORK, April 7, 2003 (PRIMEZONE) -- As the amount of time it takes the FDA to approve new drug applications has increased over the past several years, as well as the situation of fewer new drugs...